Hansoh Bio

Hansoh Bio is the United States-based research and development subsidiary of Hansoh Pharmaceutical Group, one of China's leading innovation-driven pharmaceutical companies. The company focuses on the discovery and development of transformative therapies across multiple therapeutic areas, including oncology, metabolic diseases, and central nervous system disorders. Utilizing advanced modalities such as antibody-drug conjugates (ADCs) and small molecules, Hansoh Bio aims to address significant unmet medical needs through both internal R&D and strategic global partnerships. The firm plays a critical role in Hansoh's global expansion strategy, bridging innovative science from North America with extensive manufacturing and commercialization capabilities in Asia. Notable achievements include high-value licensing deals for their ADC assets with global pharmaceutical leaders such as GSK.